SEC Form 4: Valliant John sold $16,457 worth of shares (2,181 units at $7.55) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 360,979 units

ByQuantisnow·Wall Street's wire, on your screen.

FUSN· Fusion Pharmaceuticals Inc.

Health Care

Original source

SEC Form 4: Valliant John sold $16,457 worth of shares (2,181 units at $7.55) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 360,979 units | Quantisnow